BioCardia, Inc. (Nasdaq: BCDA) said it has completed a revised Pre-Submission to the FDA's Center for Devices and Radiological Health ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE